| 查看: 811 | 回复: 0 | ||
[求助]
求助翻译 关于HIF和shRNA
|
|
求助翻译： 菜鸟一个，这段有点搞不懂作者的意图是什么。。。 To investigate the role of each of the HIF-a subunits in human HSPCs, we constructed bicistronic lentiviral vectors carrying two distinct promoters, EF1a and H1, driving green fluorescent pro- tein (GFP) (reporter) and a small hairpin RNA (shRNA) against the HIF-1a (sequence published in Rezvani et al., 2007) or HIF-2a subunit, respectively (Figure S1B). To confirm the specificity and efficiency of these vectors, CD34+ cells were transduced (45%–80% transduction efficiency), FACS-sorted 4 days post- transduction, and cultured for an additional 4 days prior to our assessment of mRNA levels. A significant reduction in mRNA levels was observed for both HIF-1a and HIF-2a vectors relative to controls, with a decrease of 88% and 78%, respectively (Fig- ure 1B). The KD was also confirmed at the protein level in CD34+ cells (Figure 1C) and in 293T cells (Figure S1C). The shHIF1a used in this study has been previously validated elsewhere (Rezvani et al., 2007). However, to confirm the specificity and exclude off-target effects of the shRNA for HIF-2a, we tested a second shHIF2a (shHIF2a.2) (Figure S1D). Using this second vector, we confirmed an efficient KD at the protein level, as well as similar defects in vivo compared to the first shRNA used (shHIF2a.1) (Figure S1E). We then used the construct that gave us the best silencing activity (shHIF2a.1) for the rest of this study. 还有构建的shRNA作用是不是就是表达HIF1a和HIF2a？ 下游靶基因的表达减少是否意味着HIF1a和HIF2a的表达减少？ |
回复此楼» 猜你喜欢
时间戳变了，能看出什么问题？
已经有20人回复
-
重要消息，中午系统在维护
已经有12人回复
-
哪位老哥知道今年的国自然具体哪一天放榜？
已经有20人回复
-
言之凿凿，8月21号(明天)放榜
已经有14人回复
-
只有每年这种时候来逛逛小木虫
已经有21人回复
-
今天基金会出结果吗？20260819
已经有15人回复
-
filecode，4个jtjc了
已经有13人回复
-
为什么余额宝的年化利率越来越低？主要原因有哪些？
已经有5人回复
-
今天放榜没戏了吧
已经有5人回复
-
今天放榜吗？
已经有15人回复
